BIOSPECIFICS TECHNOLOGIES CO's ticker is BSTC and the CUSIP is 090931106. A total of 80 filers reported holding BIOSPECIFICS TECHNOLOGIES CO in Q2 2018. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $916,000 | -57.5% | 17,337 | -50.7% | 0.00% | -100.0% |
| Q2 2020 | $2,155,000 | +26.7% | 35,176 | +17.0% | 0.00% | 0.0% |
| Q1 2020 | $1,701,000 | -0.6% | 30,059 | -0.0% | 0.00% | 0.0% |
| Q4 2019 | $1,712,000 | +47.1% | 30,070 | +38.2% | 0.00% | 0.0% |
| Q3 2019 | $1,164,000 | -9.1% | 21,757 | +1.4% | 0.00% | 0.0% |
| Q2 2019 | $1,281,000 | +74.8% | 21,459 | +82.5% | 0.00% | – |
| Q1 2019 | $733,000 | +115.6% | 11,758 | +102.1% | 0.00% | – |
| Q3 2018 | $340,000 | +28.8% | 5,819 | -1.2% | 0.00% | – |
| Q2 2018 | $264,000 | -45.5% | 5,887 | -37.3% | 0.00% | – |
| Q2 2015 | $484,000 | -7.3% | 9,384 | -29.5% | 0.00% | – |
| Q1 2015 | $522,000 | -1.5% | 13,320 | -3.1% | 0.00% | -100.0% |
| Q4 2014 | $530,000 | +2.7% | 13,743 | -5.9% | 0.00% | 0.0% |
| Q3 2014 | $516,000 | +33.0% | 14,611 | +1.4% | 0.00% | – |
| Q2 2014 | $388,000 | -10.6% | 14,411 | -14.0% | 0.00% | -100.0% |
| Q1 2014 | $434,000 | – | 16,748 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Stonepine Capital Management, LLC | 385,954 | $16,723,000 | 10.02% |
| JW Asset Management, LLC | 73,649 | $3,191,000 | 3.40% |
| Elk Creek Partners, LLC | 168,714 | $7,310,000 | 0.43% |
| NORTHPOINTE CAPITAL LLC | 80,710 | $3,497,000 | 0.39% |
| Ativo Capital Management LLC | 33,096 | $1,434,000 | 0.38% |
| RICE HALL JAMES & ASSOCIATES, LLC | 155,318 | $6,730,000 | 0.26% |
| ISTHMUS PARTNERS, LLC | 17,406 | $754,000 | 0.20% |
| Matarin Capital Management, LLC | 48,952 | $2,121,090,000 | 0.16% |
| GLOBEFLEX CAPITAL L P | 4,324 | $187,000 | 0.05% |
| Summit Trail Advisors, LLC | 6,797 | $295,000 | 0.04% |